First Opinion

First Opinion Vishal Khetpal

Compounded semaglutide is an ill-defined public health crisis

First Opinion Jack Hooper

STAT Plus: What does the presidential election mean for ICHRA and the health insurance market?

First Opinion Kendalle Burlin O’Connell

STAT Plus: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma

First Opinion Lindsey Ulin

Why so many patients are confused about CPR and do-not-resuscitate orders

First Opinion Ruby Mehta

The surgeon general’s warning on parental mental health doesn’t go far enough

First Opinion Chris Severn

How much does it cost to give birth in the U.S.?

First Opinion Michelle C. Werner

Breakthrough therapies have given Duchenne muscular dystrophy families like mine hope — and new fears

First Opinion Jeffrey Flier

STAT Plus: How Pfizer ended up passing on my GLP-1 work back in the early ’90s

First Opinion Torie Bosch

First Opinion readers on cancer screening, mpox vaccines, and more

First Opinion Mary Giliberti

Presidential debate moderators should ask about mental health policy

First Opinion Robert Steinglass, Phillip Nieburg, and Ron Waldman

Gaza polio vaccination drive must include measles shots

First Opinion William Foege, William Roper, Jeffrey Koplan, Julie Gerberding, Tom Frieden, Brenda Fitzgerald, Robert Redfield, and Rochelle Walensky

Eight former CDC directors: Hollowing out the CDC is a prescription for disaster

First Opinion Jess Steier

The truth behind that viral study on fluoride and IQ

First Opinion Ellery Biddle

The Snoo can’t help the people who need it most

First Opinion Pradeep Natarajan

Letting funding for the All of Us research program lapse will cost the U.S. far more than it saves

First Opinion Alan Levinovitz

STAT Plus: The alliance between RFK Jr. and Trump all comes down to their health-related worldview

First Opinion Ge Bai

Health care price regulation is undemocratic

First Opinion Gavin Fraser

Conversations about improving prenatal care must include transgender and gender diverse birthing people

First Opinion Peter J. Neumann, Elliott Crummer, Anna Kaltenboeck, and Sean R. Tunis

Medicare’s new transitional coverage of emerging technologies program doesn’t go far enough

First Opinion Wilfredo R. Matias

To stop mpox from becoming the next pandemic, we must address global vaccine inequities

First Opinion Jim Murphy and Lisa Lacasse

The importance of reducing the financial burden of participating in clinical trials

First Opinion Adina Wise

Who should get to see the neurologist first: the sick or the at-risk?

First Opinion Guy David

Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times

Torie Bosch

STAT readers on mask bans, cancer screening, and empathy and AI

First Opinion Daniel Morgan

Why you may not need a checkup every year

First Opinion Sophia Hua

A harm-reduction approach to eating out

First Opinion Sophie Zaaijer

In drug development, diversity must be extended to preclinical research

First Opinion Adewole Adamson, Vishal Patel, and H. Gilbert Welch

Doing more cancer screening won’t reduce Black-white health disparities

First Opinion Anand Kumar

What’s going on in Joe Biden’s brain?